FDA Panel to Review Seven Peptides Amid Rising Popularity

A U.S. FDA advisory panel is set to review seven popular peptides to determine if they can be compounded by licensed pharmacies. Despite potential regulatory hurdles, industry experts anticipate continued strong consumer demand for these substances.

22 Jul, 12:33 — 22 Jul, 12:33

Post Share

Sources

Showing 1 of 1 sources

cbcHigh20d ago

U.S. FDA panel to review 7 peptides amid growing popularity

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to remain strong.

Read full article →

PERSPECTA

PERSPECTA

FDA Panel to Review Seven Peptides Amid Rising Popularity

Sources

U.S. FDA panel to review 7 peptides amid growing popularity

Related Stories

Invisible AI Watermarks Deployed to Identify AI-Generated Text, Including in Academic Settings

Meta and TikTok Agree to Combat Disinformation After Ceuta Migrant Crisis

Solar Eclipse Poses Challenge for European Solar Farms

Vietnam's VinSpace Partners with SpaceX for First Satellite Launch

PERSPECTA